Current status and future perspectives on consensus and controversies in advanced breast cancer for 2024
Breast cancer remains the most prevalent malignancy in women, with a 5-year survival rate less than 20% in advanced stages. The deepening understanding of breast cancer pathogenesis and the emergence of novel therapeutic agents/regimens have progressively extended survival outcomes for advanced brea...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Editorial Office of China Oncology
2025-03-01
|
| Series: | Zhongguo aizheng zazhi |
| Subjects: | |
| Online Access: | http://www.china-oncology.com/fileup/1007-3639/PDF/1744268611778-1774037592.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|